Advanced search
Publication Cover
European Clinical Respiratory Journal Volume 3, 2016 - Issue 1
Submit an article Journal homepage
1,482
Views
8
CrossRef citations to date
0
Altmetric
Original Research Articles

Bad news itself or just the messenger? The high mortality of Fusobacterium spp. infections is related to disseminated malignancy and other comorbidities

Katrine JohannesenDepartment of Respiratory and Internal Medicine, Naestved Sygehus, Næstved, DenmarkCorrespondence[email protected]
,
Ram DessauDepartment of Clinical Microbiology, Slagelse Sygehus, Næstved, Denmark;Institute for Regional Health Research, University of Southern Denmark, Odense, Denmark
,
Ole HeltbergDepartment of Clinical Microbiology, Slagelse Sygehus, Næstved, Denmark
&
Uffe BodtgerDepartment of Respiratory and Internal Medicine, Naestved Sygehus, Næstved, Denmark;Institute for Regional Health Research, University of Southern Denmark, Odense, Denmark
Article: 30287 | Received 04 Nov 2015, Accepted 29 Mar 2016, Published online: 10 May 2016

References

  • Mandell CH, Garrett WS, Onderdonk AB , Bennett JE, Dolin R, Blaser MJ. Bacteroides, Prevotella, Porphyromonas, and Fusobacterium Species (and other medically important anaerobic Gram-negative bacilli). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 2015; Philadelphia, PA: Elsevier, Saunders. 2773–80. 8th ed.
  • Brazier JS, Hall V, Yusuf E, Duerden BI. Fusobacterium necrophorum infections in England and Wales 1990–2000. J Med Microbiol. 2002; 51: 269–72. [PubMed Abstract].
  • Manson McGuire A, Cochrane K, Griggs AD, Haas BJ, Abeel T, Zeng Q, etal. Evolution of invasion in a diverse set of Fusobacterium species. MBio. 2014; 5: e01864. [PubMed Abstract] [PubMed CentralFull Text].
  • Pett E, Saeed K, Dryden M. Fusobacterium species infections: clinical spectrum and outcomes at a district general hospital. Infection. 2014; 42: 363–70. [PubMed Abstract].
  • Hagelskjaer Kristensen L, Prag J. Localised Fusobacterium necrophorum infections: a prospective laboratory-based Danish study. Eur J Clin Microbiol Infect Dis. 2008; 27: 733–9. [PubMed Abstract].
  • Kristensen LH, Jensen A, Prag J. [Fusobacterium necrophorum: from tonsillitis to Lemierre's syndrome]. Ugeskr Laeger. 2009; 171: 987–90. [PubMed Abstract].
  • Kisser U, Gurkov R, Flatz W, Berghaus A, Reichel O. Lemierre syndrome: a case report. Am J Otolaryngol. 2012; 33: 159–62. [PubMed Abstract].
  • Johannesen K, Bodtger U, Heltberg O. Lemierre's syndrome: the forgotten disease. J Thromb Thrombolysis. 2014; 37: 246–8. [PubMed Abstract].
  • Hagelskjaer Kristensen L, Prag J. Human necrobacillosis, with emphasis on Lemierre's syndrome. Clin Infect Dis. 2000; 31: 524–32. [PubMed Abstract].
  • Kuppalli K, Livorsi D, Talati NJ, Osborn M. Lemierre's syndrome due to Fusobacterium necrophorum. Lancet Infect Dis. 2012; 12: 808–15. [PubMed Abstract].
  • Su CP, Huang PY, Yang CC, Lee MH. Fusobacterium bacteremia: clinical significance and outcomes. J Microbiol Immunol Infect. 2009; 42: 336–42. [PubMed Abstract].
  • Epaulard O, Brion JP, Stahl JP, Colombe B, Maurin M. The changing pattern of Fusobacterium infections in humans: recent experience with Fusobacterium bacteraemia. Clin Microbiol Infec. 2006; 12: 178–81.
  • Afra K, Laupland K, Leal J, Lloyd T, Gregson D. Incidence, risk factors, and outcomes of Fusobacterium species bacteremia. BMC Infect Dis. 2013; 13: 264. [PubMed Abstract] [PubMed CentralFull Text].
  • Goldberg EA, Venkat-Ramani T, Hewit M, Bonilla HF. Epidemiology and clinical outcomes of patients with Fusobacterium bacteraemia. Epidemiol Infect. 2013; 141: 325–9. [PubMed Abstract].
  • Brook I, Frazier EH. Aerobic and anaerobic microbiology of empyema. A retrospective review in two military hospitals. Chest. 1993; 103: 1502–7. [PubMed Abstract].
  • Brims FJ, Lansley SM, Waterer GW, Lee YC. Empyema thoracis: new insights into an old disease. Eur Respir Rev. 2010; 19: 220–8. [PubMed Abstract].
  • Justesen T. Anaerobic bacteria – with emphasize on culture and identification in laboratories of clinical microbiology. 2009. Available from: http://www.tagejustesen.dk/anaerobebakterier/ [cited 1 September 2015]..
  • Sørensen HT. Prognosen efter akut indlæggelse på Medicinsk Visitationsafsnit på Nørrebrogade, Århus Sygehus. 2010; Århus Universitetshospital: Aarhus, Denmark: Klinisk Epidemiologisk Afdeling.
  • Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, etal. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012; 22: 299–306. [PubMed Abstract] [PubMed CentralFull Text].
  • Seo SK. Infectious complications of lung cancer. Oncology (Williston Park). 2005; 19: 185–94. [PubMed Abstract] discussion 95–6, 99–203, 7–8.
  • Khan SA, Wingard JR. Infection and mucosal injury in cancer treatment. J Natl Cancer Inst Monogr. 2001; 29: 31–6. [PubMed Abstract].
  • Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VGJr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015; 28: 603–61. doi: http://dx.doi.org/10.1128/CMR.00134-14 [PubMed Abstract].
  • Kim HK, Thammavongsa V, Schneevind O, Missiakas D. Recurrent infections and immune evasion strategies of Staphylococcus aureus . Curr Opion Microbiol. 2012; 15: 92–9.
  • Allen-Vercoe E, Strauss J, Chadee K. Fusobacterium nucleatum: an emerging gut pathogen?. Gut microbes. 2011; 2: 294–8. [PubMed Abstract].

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.